Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,130 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,433
Ph III recruiting: 179
Growth YoY: +7.6%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,492)

clinicaltrialsPublishedShowing 501–550 of 1,254 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07596121	Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%	recruiting	Phase 2	60	Tang-Du HospitalOTHER	1	May 19, 2026	clinicaltrials
NCT03851445	Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer	recruiting	Phase 2 / Phase 3	10,000	SWOG Cancer Research NetworkNETWORK	1	May 18, 2026	clinicaltrials